Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi Ramasamy; Angela M. Minassian; Katie Ewer; Amy Flaxman; Pedro M. Folegatti; DR Owens; Merryn Voysey; Parvinder K. Aley; Brian Angus; Gavin Babbage; Sandra Belij‐Rammerstorfer; Lisa Berry; Sagida Bibi; Mustapha Bittaye; Katrina Cathie; Harry Chappell; Sue Charlton; Paola Cicconi; Elizabeth Clutterbuck; Rachel Colin-Jones; Christina Dold; Katherine R. W. Emary; Sofiya Fedosyuk; Michelle Fuskova; Diane Gbesemete; Catherine Green; Bassam Hallis; Mimi M. Hou; Daniel Jenkin; Carina C. D. Joe; Elizabeth J. Kelly; Simon Kerridge; Alison M. Lawrie; Alice Lelliott; May Nwe Lwin; Rebecca Makinson; Natalie G. Marchevsky; Yama F Mujadidi; Alasdair Munro; Mihaela Pacurar; Emma Plested; Jade Rand; Thomas A. Rawlinson; Sarah Rhead; Hannah Robinson; Adam Ritchie; Amy Ross-Russell; Stephen Saich; Nisha Singh; Catherine C Smith; Matthew D. Snape; Rinn Song; Richard Tarrant; Yrene Themistocleous; Kelly Thomas; Tonya Villafana; Sarah Warren; Marion Watson; Alexander D. Douglas; Adrian V. S. Hill; Teresa Lambe; Sarah C. Gilbert; Saul N. Faust; Andrew J. Pollard; Jeremy Aboagye; K. F. Adams; Aabidah Ali; Elizabeth Allen; Lauren Allen; Jennifer L. Allison; Foteini Andritsou; Rachel Anslow; Edward H. Arbe-Barnes; Megan Baker; Natalie Baker; Philip Baker; Ioana Baleanu; Debbie Barker; Eleanor Barnes; Jordan R. Barrett; Kelly M. Schiabor Barrett; Louise Bates; Alexander Batten; Kirsten Beadon; Rebecca Beckley; Duncan Bellamy; Adam Berg; Laura Muñoz Bermejo; Eleanor Berrie; Amy Beveridge; Kevin R. Bewley; Else M. Bijker; Geeta Birch; Luke Blackwell; Heather Bletchly; Caitlin L. Blundell; Susannah R. Blundell; Emma Bolam; Elena Boland; Daan Bormans

Keywords

MedicineImmunogenicityRandomized controlled trialRegimenVaccinationClinical trialYoung adultInternal medicinePediatricsImmunologyAntibody

Affiliated Institutions

Related Publications

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti , Katie Ewer , Parvinder K. Aley +97 more

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a v...

2020 The Lancet 2590 citations

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Hu-Dachuan Jiang , Ling Wang , Tao Jiang +18 more

A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID...

2020 The Lancet 1434 citations

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov , Inna V. Dolzhikova , Dmitry V. Shcheblyakov +28 more

A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in pa...

2021 The Lancet 1799 citations

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang , Gang Zeng , Hongxing Pan +17 more

With the unprecedented morbidity and mortality associated with the COVID-19 pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac (Sinovac Life Scie...

2020 The Lancet Infectious Diseases 1488 citations

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh , Robert W. Frenck , Ann R. Falsey +22 more

The safety and immunogenicity data from this U.S. phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data re...

2020 New England Journal of Medicine 2665 citations

Publication Info

Year: 2020
Type: article
Citations: 1212
Access: Closed

External Links

Citation Metrics

1212

OpenAlex

Cite This

APA Style

                            
                                    Maheshi Ramasamy, 
                                
                                    Angela M. Minassian, 
                                
                                    Katie Ewer
                                
                                et al.
                            
                            (2020). 
                            Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. 
                            Oxford University Research Archive (ORA) (University of Oxford)
                            
                            .